The latest price target for Beauty Health (NASDAQ:SKIN) was reported by Canaccord Genuity on November 13, 2024. The analyst firm set a price target for $1.75 expecting SKIN to rise to within 12 months (a possible 15.89% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Beauty Health (NASDAQ:SKIN) was provided by Canaccord Genuity, and Beauty Health maintained their hold rating.

The last upgrade for The Beauty Health Co happened on March 20, 2023 when Exane BNP Paribas raised their price target to N/A. Exane BNP Paribas previously had an underperform for The Beauty Health Co.

The last downgrade for The Beauty Health Co happened on November 15, 2023 when Jefferies changed their price target from $11 to $1.5 for The Beauty Health Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beauty Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beauty Health was filed on November 13, 2024 so you should expect the next rating to be made available sometime around November 13, 2025.

While ratings are subjective and will change, the latest Beauty Health (SKIN) rating was a maintained with a price target of $1.25 to $1.75. The current price Beauty Health (SKIN) is trading at is $1.51, which is within the analyst’s predicted range.